Brief: Ryvu Therapeutics's Project On Recommendation List For 3.1 Mln Zloty Subsidy
Nov 29 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* 'INFRAADC' PROJECT INCLUDED IN FUNDING RECOMMENDATION LIST
FOR
3.1 MILLION ZLOTY SUBSIDY
* PROJECT'S TOTAL VALUE AT 7.5 MILLION ZLOTYS
Source text: ID:nEM1LZDFKa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys